de Matteis A, Perrone V, Marone A
Minerva Med. 1977 Jul 28;68(36):2499-504.
Results with a new synthetic androgen (Calusterone) in the management of 22 cases of advanced breast cancer are presented. Reference is made to the doses employed, the therapeutic results observed, and the side-effects caused by the drug. By comparison with the literature data, a partial response to treatment was observed in 47% of the series.
本文介绍了一种新型合成雄激素（卡鲁睾酮）治疗22例晚期乳腺癌的结果。文中提及了用药剂量、观察到的治疗效果以及该药物引起的副作用。与文献数据相比，该系列病例中有47%观察到对治疗有部分反应。
